Use of CCR9, CCL25/TECK, and integrin alpha4 in diagnosis and treatment of melanoma metastasis in the small intestine

Details for Australian Patent Application No. 2008282449 (hide)

Owner John Wayne Cancer Institute

Inventors Amersi, Farin; Hoon, Dave S.B.

Agent Spruson & Ferguson

Pub. Number AU-A-2008282449

PCT Pub. Number WO2009/018170

Priority 11/829,507 27.07.07 US

Filing date 25 July 2008

Wipo publication date 5 February 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/018170 Priority application(s): WO2009/018170

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008282451-Implantable device for the brain

2008282445-Exercise performance and recovery formulations